This article delves into how digital technologies are transforming financial services in...
Fundamentals for Ambuja Cements Limited
Last Updated:
2025-04-24 19:31
Overall Fundamental outlook
Business Operations:
Sector: Basic Materials Industry: Building Materials
Ambuja Cements Limited, together with its subsidiaries, manufactures and markets cement and cement related products to individual homebuilders, masons and contractors, and architects and engineers in India. The company offers Portland pozzolana cement and ordinary Portland cement, as well as temperature resistant concrete blocks, Blaine Portland cement, and micro materials. It sells its products through dealers, authorized retail stockiest, retailers, and authorized sales representatives. The company was formerly known as Gujarat Ambuja Cements Limited and changed its name to Ambuja Cements Limited in April 2007. The company was incorporated in 1981 and is based in Ahmedabad, India. Ambuja Cements Limited operates as a subsidiary of Holderind Investments Ltd.
Revenue projections:
Revenue projections for AMBUJACEM With AMBUJACEM's revenue forecasted to drop below last year's level, investors are expected to take a cautious stance. Such declines typically affect a company's bottom line, reducing profitability and making investors hesitant to invest heavily in the company until financial performance improves.
Financial Ratios:
currentRatio
0.00000
forwardPE
36.05047
debtToEquity
1.30100
earningsGrowth
1.22500
revenueGrowth
0.14800
grossMargins
0.58025
operatingMargins
0.11233
trailingEps
17.86000
forwardEps
0.00000
AMBUJACEM's positive growth in earnings and revenue suggests the company is on track to expand its business. These indicators highlight a healthy financial performance, with AMBUJACEM expected to increase its market presence and profitability.
Price projections:
Price projections for AMBUJACEM Over time, AMBUJACEM's price projections have been gradually lowered, signaling declining confidence in the company's future outlook. The downward revisions suggest analysts are becoming more cautious about AMBUJACEM's potential for growth.
Recommendation changes over time:
Recommendations trend for AMBUJACEM
Analysts have been favoring AMBUJACEM with a buy bias recently, signaling a promising investment opportunity. This optimistic outlook may attract more investors, positioning AMBUJACEM as a desirable option for those seeking to invest their money in a stable, profitable company with strong growth potential.
DISCLAIMER: We provide information and our musings based on events, but nothing on this site can be considered professional advice of any kind.
This article examines the recent slowdown in GDP growth to 5.4 percent,...
By clicking "Accept", you agree to the storing of cookies on your device to enhance site navigation, analyze site usage and assist in our tailored marketing efforts.